US 8106160
N-terminal modified interferon-alpha
granted A61KA61K38/00A61P
Quick answer
US patent 8106160 (N-terminal modified interferon-alpha) held by PHARMAESSENTIA CORPORATION expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PHARMAESSENTIA CORPORATION
- Grant date
- Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12